Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient’s IADL?
暂无分享,去创建一个
M. Taphoorn | J. Reijneveld | S. Sikkes | L. Dirven | B. Uitdehaag | Y. Narita | A. Talacchi | I. Lips | Q. Oort | N. Aaronson | M. Sztankay | F. Boele | G. Stockhammer | R. Grant | J. Egeter | C. Brannan | M. Klein | Hitomi Sato | M. Klein